Schedule 13G ownership disclosure
Iovance Biotherapeutics Inc
Security class unavailable · CUSIP: 462260100
Event date: 2023-02-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 7,347,600
- Percent of class
- 4.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-23-001919
- Form type
- SC 13G
- Filer
- IOVANCE BIOTHERAPEUTICS, INC.
- CIK
- CIK 1425205
- Filed
- Feb 17, 2023
- Reporting period
- Feb 16, 2023
- Description
- Schedule 13G beneficial ownership